Purdue Pharma asked a bankruptcy judge late Tuesday to consider the latest version of its plan to settle thousands of lawsuits over the toll of the powerful prescription painkiller OxyContin, a deal ...

WASHINGTON, D.C. — The Mets had the perfect vantage point from their dugout as the ball skipped into the glove of Nathaniel Lowe near first base, but none of the umpiring crew seemed to have a ...

FAMU’s decision to appoint Johnson as its next president has ignited significant controversy. It’s a controversy that shows signs of festering for an extended period. Critics express concern ...

Michigan softball continued its unlikely run through the 2025 Big Ten Tournament with another victory May 9 in West Lafayette, Indiana, beating Purdue, 4-2, to advance to the final. U-M will face ...

Another settlement that would be among the largest, with members of the Sackler family who own OxyContin maker Purdue Pharma agreeing to pay up to $7 billion, could be approved this year.

Another settlement that would be among the largest, with members of the Sackler family who own OxyContin maker Purdue Pharma agreeing to pay up to $7 billion, could be approved this year.

Another settlement that would be among the largest, with members of the Sackler family who own OxyContin maker Purdue Pharma agreeing to pay up to $7 billion, could be approved this year.

After President Donald Trump signed a sweeping executive order aimed at cutting the cost of prescription drugs in the U.S., New Jersey’s pharmaceutical industry is speaking out about the plan.